In vivo study of p110alpha disruption and Ras signalling;
| Inventor | Institute |
|---|---|
| Julian Downward | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| SKU: | 151553 |
|---|---|
| Product description: | In vivo study of p110alpha disruption and Ras signalling; |
| Conditional: | No |
| Production details: | A Pi3kca targeting vector, containing substitutions at residues 208 (T to D) and 227 (K to A) and a loxP flanked resistance cassette, was transfected into 129 ES cells. Properly targeted ES cells containing a homologous recombination event were selected, cloned and injected into C57BL6 blastocysts. Chimeric offspring were backcrossed to establish heterozygous mice, which were subsequently mated to Cre transgenic mice to excise the resistance cassette. Heterozygous Pik3ca mice were interbred to establish homozygous mutants. |
| Additional notes: | The Pi3kca mouse is an ideal tool for studying cell signalling and the development of Ras or PI-3K inhibitors. Pi3kca mice express a mutated knockin form of PI-3kinase alpha (one of the main effectors of Ras signalling) which is no longer able to associate with Ras. This knockin mutation greatly increases the tumour resistance of Pi3kca mice to chemically- and K-Ras-induced tumourigenesis. In addition, the mice could be used to study the role of Ras-PI-3K signalling in inflammation, cytoskeletal reorganisation and cell motility. Pi3kca mice demonstrate deficient development and branching of the lymphatic system compared to wildtype mice. Full mouse strain name B6.129S7(Cg)-Pik3catm1Jdo/J |
| Cat. #: | 151553 |
|---|---|
| Research Fields: | Cancer; Cell signaling and signal transduction; Genetics |
| Target: | Phosphoinositide 3-Kinase C alpha (PI 3kinase) / p110alpha mutant (disrupted Ras interaction) |
| Disease: | Cancer |
| Model: | Mutant |
| Strain: | B6.129S7(Cg)-Pik3catm1Jdo/J |
| Phenotype: | Pi3kca mice express a mutated knockin form of PI-3kinase alpha (one of the main effectors of Ras signalling) which is no longer able to associate with Ras. This knockin mutation greatly increases the tumour resistance of Pi3kca mice to chemically- and K-Ras-induced tumourigenesis. In addition, the mice could be used to study the role of Ras-PI-3K signalling in inflammation, cytoskeletal reorganisation and cell motility.Pi3kca mice demonstrate deficient development and branching of the lymphatic system compared to wildtype mice |
| Shipping conditions: | Embryo/Spermatoza- Dry Ice |
|---|
| References: |
Gupta et al. 2007. Cell. 129(5):957-68. PMID: 17540175. Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.